- Home
- IBG vs SSKN Comparison
IBG vs SSKN Comparison
Compare IBG & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBG
- SSKN
- Stock Information
- Founded
- IBG 2018
- SSKN 1989
- Country
- IBG Australia
- SSKN United States
- Employees
- IBG N/A
- SSKN N/A
- Industry
- IBG Beverages (Production/Distribution)
- SSKN Medical/Dental Instruments
- Sector
- IBG Consumer Staples
- SSKN Health Care
- Exchange
- IBG Nasdaq
- SSKN Nasdaq
- Market Cap
- IBG 7.8M
- SSKN 8.9M
- IPO Year
- IBG 2024
- SSKN 2005
- Fundamental
- Price
- IBG $3.33
- SSKN $1.93
- Analyst Decision
- IBG Strong Buy
- SSKN Strong Buy
- Analyst Count
- IBG 1
- SSKN 1
- Target Price
- IBG N/A
- SSKN $6.00
- AVG Volume (30 Days)
- IBG 6.0M
- SSKN 6.2M
- Earning Date
- IBG 11-15-2025
- SSKN 11-12-2025
- Dividend Yield
- IBG N/A
- SSKN N/A
- EPS Growth
- IBG N/A
- SSKN N/A
- EPS
- IBG N/A
- SSKN N/A
- Revenue
- IBG $2,931,243.00
- SSKN $32,848,000.00
- Revenue This Year
- IBG N/A
- SSKN N/A
- Revenue Next Year
- IBG N/A
- SSKN $9.70
- P/E Ratio
- IBG N/A
- SSKN N/A
- Revenue Growth
- IBG N/A
- SSKN 0.36
- 52 Week Low
- IBG $1.48
- SSKN $1.38
- 52 Week High
- IBG $11.50
- SSKN $3.86
- Technical
- Relative Strength Index (RSI)
- IBG 62.66
- SSKN 49.27
- Support Level
- IBG $2.16
- SSKN $2.00
- Resistance Level
- IBG $5.38
- SSKN $2.16
- Average True Range (ATR)
- IBG 0.72
- SSKN 0.27
- MACD
- IBG 0.10
- SSKN 0.00
- Stochastic Oscillator
- IBG 48.70
- SSKN 33.33
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.